Trials / Completed
CompletedNCT01467726
Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects
A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Study of Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Alfasigma S.p.A. · Industry
- Sex
- All
- Age
- 65 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
This is a Phase 1, Randomized, Placebo-Controlled, Double-Blind, Study of Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Velusetrag | Capsules |
| DRUG | Velusetrag | Capsules |
| DRUG | Placebo | Capsules |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2011-11-09
- Last updated
- 2025-07-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01467726. Inclusion in this directory is not an endorsement.